Regorafenib-induced hand-foot skin reaction in an adolescent
Last Updated: Wednesday, May 21, 2025
In this case report, an adolescent with metastatic osteosarcoma developed severe, grade 3 regorafenib-induced hand-foot skin reaction (HFSR). This HFSR limited her ability to ambulate. The case demonstrates management involving supportive measures and temporary discontinuation of regorafenib, highlighting the absence of standard pediatric guidelines.
Advertisement
News & Literature Highlights